NCT04242849View on ClinicalTrials.gov

IDH1/2 Mutational Analysis in AML Patients: Diagnosis and Follow-up

CompletedOBSERVATIONAL
Enrollment

354

Participants

Timeline

Start Date

May 23, 2016

Primary Completion Date

December 27, 2019

Study Completion Date

January 16, 2020

Conditions
Acute Myeloid Leukemia
Sponsors

Collaborators (1)

Celgene
All Listed Sponsors
collaborator

Celgene

INDUSTRY

lead

Josep Carreras Leukaemia Research Institute

OTHER